Tapewire

NYSE · USD

ABT

ABBOTT LABORATORIES

Export transactions ↓
Tapewire entity
2314
SEC CIK
0000001800
Parsed reports
2,562

Last 12 months

Inside the activity.

6 purchase rows · 11 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202610
Feb 202620
Mar 202606
Apr 202620
May 202610
Jun 202600
Jul 202600
Aug 202603
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 24, 2018 Filed Jul 26, 2018 21:09 UTC
Blaser Brian J.Executive Vice President
SaleCommon shares without par value 608 $63.95 $38,881.60
Disclosure

SEC source: 0001179110-18-009935 · edgar.xml · nonDerivative · entry 11

Blaser Brian J · CIK 0001492289 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,326

Read SEC document
July 24, 2018 Filed Jul 26, 2018 21:09 UTC
Blaser Brian J.Executive Vice President
SaleCommon shares without par value 484 $63.95 $30,949.38
Disclosure

SEC source: 0001179110-18-009935 · edgar.xml · nonDerivative · entry 10

Blaser Brian J · CIK 0001492289 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,934

Read SEC document
July 24, 2018 Filed Jul 26, 2018 21:09 UTC
Blaser Brian J.Executive Vice President
SaleCommon shares without par value 100 $63.94 $6,394.00
Disclosure

SEC source: 0001179110-18-009935 · edgar.xml · nonDerivative · entry 9

Blaser Brian J · CIK 0001492289 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,418

Read SEC document
July 24, 2018 Filed Jul 26, 2018 21:09 UTC
Blaser Brian J.Executive Vice President
SaleCommon shares without par value 100 $63.93 $6,392.50
Disclosure

SEC source: 0001179110-18-009935 · edgar.xml · nonDerivative · entry 8

Blaser Brian J · CIK 0001492289 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,518

Read SEC document
July 24, 2018 Filed Jul 26, 2018 21:09 UTC
Blaser Brian J.Executive Vice President
SaleCommon shares without par value 200 $63.92 $12,784.00
Disclosure

SEC source: 0001179110-18-009935 · edgar.xml · nonDerivative · entry 7

Blaser Brian J · CIK 0001492289 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,618

Read SEC document
July 24, 2018 Filed Jul 26, 2018 21:09 UTC
Blaser Brian J.Executive Vice President
SaleCommon shares without par value 300 $63.92 $19,174.50
Disclosure

SEC source: 0001179110-18-009935 · edgar.xml · nonDerivative · entry 6

Blaser Brian J · CIK 0001492289 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,818

Read SEC document
July 24, 2018 Filed Jul 26, 2018 21:09 UTC
Blaser Brian J.Executive Vice President
SaleCommon shares without par value 100 $63.91 $6,391.00
Disclosure

SEC source: 0001179110-18-009935 · edgar.xml · nonDerivative · entry 5

Blaser Brian J · CIK 0001492289 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,118

Read SEC document
July 24, 2018 Filed Jul 26, 2018 21:09 UTC
Blaser Brian J.Executive Vice President
SaleCommon shares without par value 200 $63.91 $12,781.00
Disclosure

SEC source: 0001179110-18-009935 · edgar.xml · nonDerivative · entry 4

Blaser Brian J · CIK 0001492289 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,218

Read SEC document
July 24, 2018 Filed Jul 26, 2018 21:09 UTC
Blaser Brian J.Executive Vice President
SaleCommon shares without par value 100 $63.90 $6,390.00
Disclosure

SEC source: 0001179110-18-009935 · edgar.xml · nonDerivative · entry 3

Blaser Brian J · CIK 0001492289 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,418

Read SEC document
July 24, 2018 Filed Jul 26, 2018 21:09 UTC
Blaser Brian J.Executive Vice President
SaleCommon shares without par value 200 $63.89 $12,778.00
Disclosure

SEC source: 0001179110-18-009935 · edgar.xml · nonDerivative · entry 2

Blaser Brian J · CIK 0001492289 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,518

Read SEC document
July 24, 2018 Filed Jul 26, 2018 21:09 UTC
Blaser Brian J.Executive Vice President
SaleCommon shares without par value 200 $63.89 $12,777.00
Disclosure

SEC source: 0001179110-18-009935 · edgar.xml · nonDerivative · entry 1

Blaser Brian J · CIK 0001492289 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,718

Read SEC document
July 23, 2018 Filed Jul 24, 2018 21:02 UTC
PEDERSON MICHAEL JSenior Vice President
SaleCommon shares without par value 247 $63.20 $15,610.40
Disclosure

SEC source: 0001179110-18-009886 · edgar.xml · nonDerivative · entry 2

PEDERSON MICHAEL J · CIK 0001712233 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,220

Read SEC document
July 23, 2018 Filed Jul 24, 2018 21:01 UTC
Bracken Sharon JSenior Vice President
SaleCommon shares without par value 259 $63.20 $16,368.80
Disclosure

SEC source: 0001179110-18-009885 · edgar.xml · nonDerivative · entry 1

Bracken Sharon J · CIK 0001710778 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,376

Read SEC document
July 21, 2018 Filed Jul 24, 2018 21:02 UTC
PEDERSON MICHAEL JSenior Vice President
Tax withholdingCommon shares without par value 1,637 $63.32 $103,654.84
Disclosure

SEC source: 0001179110-18-009886 · edgar.xml · nonDerivative · entry 1

PEDERSON MICHAEL J · CIK 0001712233 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,467

Read SEC document
July 21, 2018 Filed Jul 24, 2018 21:02 UTC
Salvadori Daniel Gesua SiveExecutive Vice President
Tax withholdingCommon shares without par value 1,060 $63.32 $67,119.20
Disclosure

SEC source: 0001179110-18-009887 · edgar.xml · nonDerivative · entry 1

Salvadori Daniel Gesua Sive · CIK 0001620564 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,521

Read SEC document
July 21, 2018 Filed Jul 24, 2018 21:03 UTC
Wellisch Alejandro DSenior Vice President
Tax withholdingCommon shares without par value 525 $63.32 $33,243.00
Disclosure

SEC source: 0001179110-18-009888 · edgar.xml · nonDerivative · entry 2

Wellisch Alejandro D · CIK 0001717526 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,066

Read SEC document
July 21, 2018 Filed Jul 24, 2018 21:03 UTC
Wellisch Alejandro DSenior Vice President
GrantCommon shares without par value 1,498 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-009888 · edgar.xml · nonDerivative · entry 1

Wellisch Alejandro D · CIK 0001717526 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,591

F1 · shares: Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
July 10, 2018 Filed Jul 12, 2018 21:01 UTC
Bracken Sharon JSenior Vice President
Tax withholdingCommon shares without par value 505 $62.44 $31,532.20
Disclosure

SEC source: 0001179110-18-009647 · edgar.xml · nonDerivative · entry 1

Bracken Sharon J · CIK 0001710778 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,635

Read SEC document
June 30, 2018 Filed Jul 3, 2018 21:06 UTC GrantStock Equivalent Units · Derivative 129 $60.99 $7,867.71
Disclosure

SEC source: 0001179110-18-009367 · edgar.xml · derivative · entry 1

Alpern Robert J · CIK 0001448074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,995

Underlying: Common shares · 129 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 30, 2018 Filed Jul 3, 2018 21:07 UTC GrantStock Equivalent Units · Derivative 516 $60.99 $31,470.84
Disclosure

SEC source: 0001179110-18-009368 · edgar.xml · derivative · entry 1

Stratton John G · CIK 0001385262 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,200

Underlying: Common shares · 516 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 30, 2018 Filed Jul 3, 2018 21:08 UTC
PEDERSON MICHAEL JSenior Vice President
Tax withholdingCommon shares without par value 504 $60.99 $30,738.96
Disclosure

SEC source: 0001179110-18-009370 · edgar.xml · nonDerivative · entry 1

PEDERSON MICHAEL J · CIK 0001712233 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,104

Read SEC document
June 15, 2018 Filed Jun 19, 2018 21:03 UTC
Watkin JaredSenior Vice President
Tax withholdingCommon shares without par value 1,875 $62.96 $118,050.00
Disclosure

SEC source: 0001179110-18-008792 · edgar.xml · nonDerivative · entry 1

Watkin Jared · CIK 0001645118 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,640

Read SEC document
June 06, 2018 Filed Jun 7, 2018 21:09 UTC
WHITE MILES DDirector · Chairman and CEO
GiftCommon shares without par value 23,923 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-008228 · edgar.xml · nonDerivative · entry 1

WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,134,185

Read SEC document
June 05, 2018 Filed Jun 7, 2018 21:08 UTC
Funck, Jr. Robert E.Senior Vice President
Exercise / conversionOption (right to buy) · Derivative 12,800 $0.00 Strike: $26.02 $0.00
Disclosure

SEC source: 0001179110-18-008227 · edgar.xml · derivative · entry 6

Funck Robert E · CIK 0001565892 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 12,800 shares

Expires 2019-02-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
June 05, 2018 Filed Jun 7, 2018 21:08 UTC
Funck, Jr. Robert E.Senior Vice President
Tax withholdingCommon shares without par value 8,613 $63.02 $542,791.26
Disclosure

SEC source: 0001179110-18-008227 · edgar.xml · nonDerivative · entry 2

Funck Robert E · CIK 0001565892 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,680

Read SEC document
June 05, 2018 Filed Jun 7, 2018 21:08 UTC
Funck, Jr. Robert E.Senior Vice President
Exercise / conversionCommon shares without par value 12,800 $26.02 $332,992.00
Disclosure

SEC source: 0001179110-18-008227 · edgar.xml · nonDerivative · entry 1

Funck Robert E · CIK 0001565892 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,293

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2018 Filed Jun 5, 2018 21:01 UTC
Ford Robert BExecutive Vice President
Tax withholdingCommon shares without par value 299 $61.53 $18,397.47
Disclosure

SEC source: 0001179110-18-008098 · edgar.xml · nonDerivative · entry 1

Ford Robert B · CIK 0001612571 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,775

Read SEC document
June 01, 2018 Filed Jun 5, 2018 21:03 UTC
LANE ANDREW HExecutive Vice President
Tax withholdingCommon shares without par value 602 $61.53 $37,041.06
Disclosure

SEC source: 0001179110-18-008103 · edgar.xml · nonDerivative · entry 2

LANE ANDREW H · CIK 0001643735 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,676

F2 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 01, 2018 Filed Jun 5, 2018 21:03 UTC
LANE ANDREW HExecutive Vice President
GrantCommon shares without par value 3,007 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-008103 · edgar.xml · nonDerivative · entry 1

LANE ANDREW H · CIK 0001643735 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,276

F1 · shares: Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
June 01, 2018 Filed Jun 5, 2018 21:04 UTC
YOOR BRIAN BExecutive Vice President & CFO
Tax withholdingCommon shares without par value 1,713 $61.53 $105,400.89
Disclosure

SEC source: 0001179110-18-008105 · edgar.xml · nonDerivative · entry 1

YOOR BRIAN B · CIK 0001643528 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,475

Read SEC document
May 18, 2018 Filed May 21, 2018 21:16 UTC
Salvadori Daniel Gesua SiveExecutive Vice President
SaleCommon shares without par value 1,000 $61.50 $61,500.00
Disclosure

SEC source: 0001179110-18-007253 · edgar.xml · nonDerivative · entry 2

Salvadori Daniel Gesua Sive · CIK 0001620564 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,581

Read SEC document
May 17, 2018 Filed May 21, 2018 21:16 UTC
Salvadori Daniel Gesua SiveExecutive Vice President
SaleCommon shares without par value 2,000 $61.05 $122,092.00
Disclosure

SEC source: 0001179110-18-007253 · edgar.xml · nonDerivative · entry 1

Salvadori Daniel Gesua Sive · CIK 0001620564 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,581

Read SEC document
May 15, 2018 Filed May 16, 2018 21:08 UTC
Shrimpton SeanSenior Vice President
Tax withholdingCommon shares without par value 811 $62.02 $50,298.22
Disclosure

SEC source: 0001179110-18-006899 · edgar.xml · nonDerivative · entry 2

Shrimpton Sean · CIK 0001706711 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,646

Read SEC document
May 15, 2018 Filed May 16, 2018 21:08 UTC
Shrimpton SeanSenior Vice President
GrantCommon shares without par value 1,801 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-006899 · edgar.xml · nonDerivative · entry 1

Shrimpton Sean · CIK 0001706711 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,457

F1 · shares: Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3.

Read SEC document
May 04, 2018 Filed May 8, 2018 21:00 UTC
Bracken Sharon JSenior Vice President
SaleCommon shares without par value 1,000 $58.57 $58,565.00
Disclosure

SEC source: 0001179110-18-006429 · edgar.xml · nonDerivative · entry 4

Bracken Sharon J · CIK 0001710778 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,140

Read SEC document
May 04, 2018 Filed May 8, 2018 21:00 UTC
Bracken Sharon JSenior Vice President
SaleCommon shares without par value 450 $58.56 $26,352.45
Disclosure

SEC source: 0001179110-18-006429 · edgar.xml · nonDerivative · entry 3

Bracken Sharon J · CIK 0001710778 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,140

Read SEC document
May 04, 2018 Filed May 8, 2018 21:00 UTC
Bracken Sharon JSenior Vice President
SaleCommon shares without par value 400 $58.56 $23,424.04
Disclosure

SEC source: 0001179110-18-006429 · edgar.xml · nonDerivative · entry 2

Bracken Sharon J · CIK 0001710778 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,590

Read SEC document
May 04, 2018 Filed May 8, 2018 21:00 UTC
Bracken Sharon JSenior Vice President
SaleCommon shares without par value 300 $58.56 $17,568.00
Disclosure

SEC source: 0001179110-18-006429 · edgar.xml · nonDerivative · entry 1

Bracken Sharon J · CIK 0001710778 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,990

Read SEC document
April 27, 2018 Filed May 1, 2018 23:08 UTC GrantCommon shares without par value 2,945 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-006022 · edgar.xml · nonDerivative · entry 1

Alpern Robert J · CIK 0001448074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,165

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 27, 2018 Filed May 1, 2018 23:09 UTC GrantOption (right to buy) · Derivative 15,348 $0.00 Strike: $59.42 $0.00
Disclosure

SEC source: 0001179110-18-006023 · edgar.xml · derivative · entry 2

AUSTIN ROXANNE S · CIK 0001061632 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,348

Underlying: Common shares · 15,348 shares

Expires 2028-04-26

F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
April 27, 2018 Filed May 1, 2018 23:09 UTC GrantCommon shares without par value 2,945 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-006023 · edgar.xml · nonDerivative · entry 1

AUSTIN ROXANNE S · CIK 0001061632 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,672

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 27, 2018 Filed May 1, 2018 23:09 UTC GrantCommon shares without par value 2,945 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-006024 · edgar.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,525

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 27, 2018 Filed May 1, 2018 23:10 UTC GrantOption (right to buy) · Derivative 15,247 $0.00 Strike: $59.42 $0.00
Disclosure

SEC source: 0001179110-18-006025 · edgar.xml · derivative · entry 2

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,247

Underlying: Common shares · 15,247 shares

Expires 2028-04-26

F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
April 27, 2018 Filed May 1, 2018 23:10 UTC GrantCommon shares without par value 2,945 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-006025 · edgar.xml · nonDerivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,912

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 27, 2018 Filed May 1, 2018 23:10 UTC GrantOption (right to buy) · Derivative 13,328 $0.00 Strike: $59.42 $0.00
Disclosure

SEC source: 0001179110-18-006026 · edgar.xml · derivative · entry 2

McKinstry Nancy · CIK 0001294731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,328

Underlying: Common shares · 13,328 shares

Expires 2028-04-26

F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
April 27, 2018 Filed May 1, 2018 23:10 UTC GrantCommon shares without par value 2,945 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-006026 · edgar.xml · nonDerivative · entry 1

McKinstry Nancy · CIK 0001294731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,425

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 27, 2018 Filed May 1, 2018 23:11 UTC GrantOption (right to buy) · Derivative 14,237 $0.00 Strike: $59.42 $0.00
Disclosure

SEC source: 0001179110-18-006027 · edgar.xml · derivative · entry 2

NOVAKOVIC PHEBE N · CIK 0001222195 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,237

Underlying: Common shares · 14,237 shares

Expires 2028-04-26

F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
April 27, 2018 Filed May 1, 2018 23:11 UTC GrantCommon shares without par value 2,945 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-006027 · edgar.xml · nonDerivative · entry 1

NOVAKOVIC PHEBE N · CIK 0001222195 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,092

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 27, 2018 Filed May 1, 2018 23:12 UTC GrantOption (right to buy) · Derivative 15,752 $0.00 Strike: $59.42 $0.00
Disclosure

SEC source: 0001179110-18-006028 · edgar.xml · derivative · entry 2

OSBORN WILLIAM A · CIK 0001171797 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,752

Underlying: Common shares · 15,752 shares

Expires 2028-04-26

F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
April 27, 2018 Filed May 1, 2018 23:12 UTC GrantCommon shares without par value 2,945 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-006028 · edgar.xml · nonDerivative · entry 1

OSBORN WILLIAM A · CIK 0001171797 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,082

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.